Madrigal Pharmaceuticals
MDGL
$205.25
Share price
-0.81%
Change (1 day)
-28.76%
Change (1 year)
Categories
Madrigal Pharmaceuticals (MDGL) - P/B ratio
P/B ratio as of May 2024 : 10.8
According to Madrigal Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 10.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Madrigal Pharmaceuticals - P/B ratio (from 2007 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 11.3 | -57.04% |
| 2022-12-31 | 26.2 | 255.13% |
| 2021-12-31 | 7.39 | 3.11% |
| 2020-12-31 | 7.17 | 112.32% |
| 2019-12-31 | 3.37 | -7.33% |
| 2018-12-31 | 3.64 | -49.18% |
| 2017-12-31 | 7.17 | 51.33% |
| 2016-12-31 | 4.73 | -577.5% |
| 2015-12-31 | -0.9916 | -122.34% |
| 2014-12-31 | 4.44 | -51.2% |
| 2013-12-31 | 9.10 | 9.84% |
| 2012-12-31 | 8.28 | -47.06% |
| 2011-12-31 | 15.6 | 42.61% |
| 2010-12-31 | 11.0 | 58.96% |
| 2009-12-31 | 6.90 | -295.47% |
| 2008-12-31 | -3.53 | -138.73% |
| 2007-12-31 | 9.12 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6297 | -94.16% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -81.83% | 🇺🇸 USA |